Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 248 participants.

Also called NCT04195568

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 248 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04195568
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Canada (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04195568. Allocation not applicable; no masking; primary purpose treatment. Start 2020-07-07 (actual); primary completion 2025-07-14 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System
Acronym
EVOLVE
Condition
Aneurysm, Intracranial
Intervention (Device)
Surpass Evolve Flow Diverter System
Lead sponsor
Stryker Neurovascular (class: industry)

Record details

Record id
cardio:ct-nct04195568
Content hash
4e19da9ecd3cffb7a8a95f8d0143353ee91a4ef3eafcae2b4452c80adb42279d